These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 27156108)
1. The role of complement activation in thrombosis and hemolytic anemias. Chapin J; Terry HS; Kleinert D; Laurence J Transfus Apher Sci; 2016 Apr; 54(2):191-8. PubMed ID: 27156108 [TBL] [Abstract][Full Text] [Related]
2. Complement in hemolytic anemia. Brodsky RA Hematology Am Soc Hematol Educ Program; 2015; 2015():385-91. PubMed ID: 26637747 [TBL] [Abstract][Full Text] [Related]
3. Coagulation in the pathophysiology of hemolytic anemias. Cappellini MD Hematology Am Soc Hematol Educ Program; 2007; ():74-8. PubMed ID: 18024612 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future. Risitano AM; Marotta S Semin Immunol; 2016 Jun; 28(3):223-40. PubMed ID: 27346521 [TBL] [Abstract][Full Text] [Related]
5. Complement in hemolytic anemia. Brodsky RA Blood; 2015 Nov; 126(22):2459-65. PubMed ID: 26582375 [TBL] [Abstract][Full Text] [Related]
6. Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation. Chen JY; Galwankar NS; Emch HN; Menon SS; Cortes C; Thurman JM; Merrill SA; Brodsky RA; Ferreira VP Front Immunol; 2020; 11():1460. PubMed ID: 32793201 [TBL] [Abstract][Full Text] [Related]
7. Molecular pharmacology in complement-mediated hemolytic disorders. Bortolotti M; Barcellini W; Fattizzo B Eur J Haematol; 2023 Sep; 111(3):326-336. PubMed ID: 37308291 [TBL] [Abstract][Full Text] [Related]
8. It takes two to thrombosis: Hemolysis and complement. Delvasto-Nuñez L; Jongerius I; Zeerleder S Blood Rev; 2021 Nov; 50():100834. PubMed ID: 33985796 [TBL] [Abstract][Full Text] [Related]
9. Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature. Fattizzo B; Pasquale R; Bellani V; Barcellini W; Kulasekararaj AG Front Immunol; 2021; 12():791429. PubMed ID: 34899761 [TBL] [Abstract][Full Text] [Related]
10. Oxidative stress in paroxysmal nocturnal hemoglobinuria and other conditions of complement-mediated hemolysis. Fibach E; Dana M Free Radic Biol Med; 2015 Nov; 88(Pt A):63-9. PubMed ID: 25937178 [TBL] [Abstract][Full Text] [Related]
11. Complement activation in diseases presenting with thrombotic microangiopathy. Meri S Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117 [TBL] [Abstract][Full Text] [Related]
12. Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia. DeZern AE; Brodsky RA Hematol Oncol Clin North Am; 2015 Jun; 29(3):479-94. PubMed ID: 26043387 [TBL] [Abstract][Full Text] [Related]
13. Complement the hemostatic system: an intimate relationship. Weitz IC Thromb Res; 2014 May; 133 Suppl 2():S117-21. PubMed ID: 24862131 [TBL] [Abstract][Full Text] [Related]
14. Novel insights into the treatment of complement-mediated hemolytic anemias. Berentsen S; Hill A; Hill QA; Tvedt THA; Michel M Ther Adv Hematol; 2019; 10():2040620719873321. PubMed ID: 31523413 [TBL] [Abstract][Full Text] [Related]
16. Rise of the planet of rare anemias: An update on emerging treatment strategies. Fattizzo B; Motta I Front Med (Lausanne); 2022; 9():1097426. PubMed ID: 36698833 [TBL] [Abstract][Full Text] [Related]
17. [Hemolytic anemias and vitamin B12 deficieny]. Dietzfelbinger H; Hubmann M Dtsch Med Wochenschr; 2015 Aug; 140(17):1302-10; quiz 1311-2. PubMed ID: 26306021 [TBL] [Abstract][Full Text] [Related]